A recent study has uncovered a new target for cancer therapies: the ribosome. Scientists from the University of Melbourne have found that a small molecule called martynoside stabilizes ribosome biogenesis, a process essential for protein production in the body. This suggests that martynoside, or a similar molecule, could be used in combination with existing chemotherapy drugs such as fluorouracil to improve treatments for cancer. The findings of this research could lead to new treatments for cancers that are resistant to traditional chemotherapy.

Read Full Article Here

source: Phys.org